Novozymes A/S (OTCMKTS:NVZMY) Hits New 52-Week Low at $41.62

Novozymes A/S (OTCMKTS:NVZMY) shares hit a new 52-week low on Tuesday . The stock traded as low as $41.62 and last traded at $41.87, with a volume of 53702 shares changing hands. The stock had previously closed at $42.56.

Novozymes A/S Stock Performance

The business’s fifty day moving average price is $46.48 and its 200-day moving average price is $48.66. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.35 and a quick ratio of 0.81. The stock has a market capitalization of $9.52 billion, a PE ratio of 24.60, a P/E/G ratio of 13.90 and a beta of 0.73.

Novozymes A/S (OTCMKTS:NVZMY) last posted its earnings results on Tuesday, August 8th. The biotechnology company reported $0.32 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.41 by ($0.09). The firm had revenue of $616.21 million during the quarter. Novozymes A/S had a return on equity of 24.65% and a net margin of 19.19%. As a group, equities research analysts expect that Novozymes A/S will post 1.74 EPS for the current year.

About Novozymes A/S

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Europe, the Middle East, Africa, North America, the Asia Pacific, and Latin America. The company offers baking, beverages, dairy, starch, and protein solutions for the food and beverage industry; laundry, dishwashing, and professional cleaning solutions for the household care industry; agriculture solutions, including crop production, and animal health and nutrition solutions; bioyield and biocontrol solutions for crops; and grain and technical processing solutions, as well as bio energy solutions for liquefaction, saccharifaction, fermentation, fiber conversion, and biomass conversion.